Talking to Pierre van Weperen - European Medical Journal

Continue

Talking to Pierre van Weperen

EMJ GOLD
Season 01: episode 52

GOLD is joined by Pierre van Weperen, Chief Commercial Officer, Grow Biotech. He discusses the potential of medicinal cannabis and consider the differences between working in big pharma vs in a start-up.

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.

Thank you!

Please share some more information on the rating you have given